Insilico Medicine’s Generative AI-designed Drug ISM001-055 Shows Promising Results in Phase IIa Clinical Trials In a ...

In this continuation of my last article, we will explore these challenges, the opportunities they present and the future ...

PlaqueTec, a company identifying endotype-specific biomarkers to advance precision medicine for coronary artery disease (CAD) ...

Researchers at multiple AViDD centers confirm that the NIH has offered a 1-year, no-cost extension, but it doesn’t come with ...

Adam Steensberg leads Zealand Pharma, a Danish drug maker whose stock has risen by more than 800 per cent since he took over ...

Antibiotic resistance is a global public health threat. Modern health systems rely on antibiotics to prevent and treat ...

Insilico Medicine, a clinical-stage generative AI-driven drug discovery company, announced positive preliminary results ...

This is the latest in a string of tie-ups by Anglo-Swedish drugmaker AstraZeneca to use artificial intelligence for drug ...

Recursion Pharmaceuticals has an exciting approach to developing therapies. The company recently reported positive phase 2 ...

An international placebo-controlled study led by Cedars-Sinai suggests that a targeted drug therapy that was developed by ...

Eradivir $10.25M Series A funding round Two Eradivir employees conduct research on the company’s EV25 influenza therapeutic.